Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicent... by Gianni, Luca, Dr, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Roman, Laslo, MD, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Staroslawska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia, MD, Szado, Tania, PhD, Ratnayake, Jayantha, BSc, Ross, Graham, MD, Valagussa, Pinuccia, BS

Get full text

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, op... by Gianni, Luca, Prof, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Starosławska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia Valeria, MD, Magazzù, Domenico, PhD, McNally, Virginia, PhD, Douthwaite, Hannah, MSc, Ross, Graham, FFPM, Valagussa, Pinuccia, BS

Get full text

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment... by Harbeck, Nadia, Prof, Huang, Chiun-Sheng, Prof, Hurvitz, Sara, MD, Yeh, Dah-Cherng, MD, Shao, Zhimin, Prof, Im, Seock-Ah, Prof, Jung, Kyung Hae, Prof, Shen, Kunwei, MD, Ro, Jungsil, MD, Jassem, Jacek, Prof, Zhang, Qingyuan, Prof, Im, Young-Hyuck, MD, Wojtukiewicz, Marek, Prof, Sun, Qiang, MD, Chen, Shin-Cheh, Prof, Goeldner, Rainer-Georg, PhD, Uttenreuther-Fischer, Martina, MD, Xu, Binghe, Prof, Piccart-Gebhart, Martine, MD

Get full text